Welcome to the international HTA database

Showing [16381 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2023	NIHR Health Technology Assessment programme	Insights from UKCTOCS for design, conduct and analyses of large randomised controlled trials
2023	NIHR Health Technology Assessment programme	Antidepressants in pregnancy: applying causal epidemiological methods to understand service-use outcomes in women and long-term neurodevelopmental outcomes in exposed children
2023	NIHR Health Technology Assessment programme	Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysis
2023	NIHR Health Technology Assessment programme	Helping pregnant smokers quit: a multi-centre randomised controlled trial of electronic cigarettes versus nicotine replacement therapy
2023	NIHR Health Technology Assessment programme	A randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery for open globe trauma – the ASCOT study
2023	NIHR Health Technology Assessment programme	Frenotomy with breastfeeding support versus breastfeeding support alone for infants with tongue-tie and breastfeeding difficulties: the FROSTTIE RCT
2023	NIHR Health Services and Delivery Research programme	Vertical integration of general practices with acute hospitals in England: rapid impact evaluation
2023	NIHR Health Services and Delivery Research programme	Integration, effectiveness and costs of different models of primary health care provision for people who are homeless: an evaluation study
2023	NIHR Health Services and Delivery Research programme	Explanation of context, mechanisms and outcomes in adult community mental health crisis care: the MH-CREST realist evidence synthesis
2023	Austrian Institute for Health Technology Assessment (AIHTA)	Biomarkers in Alzheimer's disease
2023	NIHR Health Services and Delivery Research programme	Identifying models of care to improve outcomes for older people with urgent care needs: a mixed methods approach to develop a system dynamics model
2023	NIHR Health Services and Delivery Research programme	What happens after an NHS Health Check? A survey and realist review
2023	NIHR Health Services and Delivery Research programme	A rapid mixed-methods evaluation of remote home monitoring models during the COVID-19 pandemic in England
2023	NIHR Health and Social Care Delivery Program	Rapid evaluation of service innovations in health and social care: key considerations
2023	Health Information and Quality Authority (HIQA)	Rapid health technology assessment of continuous glucose monitoring in adults with type 1 diabetes mellitus
2023	Institute for Clinical and Economic Review (ICER)	Assessment of barriers to fair access
2023	Institute for Clinical and Economic Review (ICER)	Advancing health technology assessment methods that support health equity
2023	Institute for Clinical and Economic Review (ICER)	Applying the results of comparative effectiveness research to control drug costs: policy options for California
2023	Institute for Clinical and Economic Review (ICER)	White bagging, brown bagging, and site of service policies: best practices in addressing provider markup in the commercial insurance market
2023	Institute for Clinical and Economic Review (ICER)	ICER-PHTI assessment framework for digital health technologies
2023	Institute for Clinical and Economic Review (ICER)	Value assessment framework
2023	Institute for Clinical and Economic Review (ICER)	Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: effectiveness and value
2023	Institute for Clinical and Economic Review (ICER)	Lecanemab for early Alzheimer’s disease
2023	Institute for Clinical and Economic Review (ICER)	Resmetirom and obeticholic acid for non-alcoholic steatohepatitis (NASH)
2023	Institute for Clinical and Economic Review (ICER)	Gene therapies for sickle cell disease: effectiveness and value
2023	Institute for Clinical and Economic Review (ICER)	Fezolinetant for moderate to severe vasomotor symptoms associated with menopause: effectiveness and value
2023	Canadian Agency for Drugs and Technologies in Health (CADTH)	Treatment of adult patients with chronic immune thrombocytopenia after failure of first-line therapies
2023	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dental bridges for partial tooth loss
2023	WorkSafeBC	Cold plunges as treatment for concussions
2023	WorkSafeBC	Flotation therapy as treatment for concussions
2023	WorkSafeBC	Efficacy of under-mask beard covers in quantitative fit testing of tight-fitting disposable respirators
2023	WorkSafeBC	Causal association between COVID-19 infection and irritable larynx syndrome
2023	WorkSafeBC	Migraines and the (Moderna) COVID-19 vaccine
2023	WorkSafeBC	Botulinum toxin as treatment for neck strains
2023	WorkSafeBC	Esketamine as treatment for depression and PTSD
2023	WorkSafeBC	Platelet rich plasma in treating (recurrent) anterior shoulder dislocation
2023	WorkSafeBC	Causal association between carpal tunnel release surgery and trigger finger
2023	WorkSafeBC	Causal association between SARS-Cov-2 infection and the development of trigeminal neuralgia
2023	Health Technology Wales (HTW)	Control contact lenses and spectacles for the treatment of myopia in children
2023	Health Information and Quality Authority (HIQA)	Methods for generic justification of new practices in ionising radiation
2023	Health Information and Quality Authority (HIQA)	Analysis of public consultation surveys to inform the work of the Public Health Reform Expert Advisory Group [protocols and report]
2023	Health Information and Quality Authority (HIQA)	Rapid health technology assessment of the extension of the seasonal influenza vaccination programme to include those aged 50 to 64 years (general population)
2023	NIHR Health Technology Assessment programme	Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation
2023	Agency for Healthcare Research and Quality (AHRQ)	Use of telehealth during the COVID-19 era
2023	Agency for Healthcare Research and Quality (AHRQ)	Radiation therapy for metastatic bone disease: effectiveness and harms
2023	Agency for Healthcare Research and Quality (AHRQ)	Postpartum care up to 1 year after pregnancy: a systematic review and meta-analysis
2023	Agency for Healthcare Research and Quality (AHRQ)	Pharmacologic and nonpharmacologic treatments for posttraumatic stress disorder: an update of the PTSD repository evidence base
2023	Agency for Healthcare Research and Quality (AHRQ)	Partial breast irradiation for breast cancer
2023	Agency for Healthcare Research and Quality (AHRQ)	Nutrition as prevention for improved cancer health outcomes
2023	Agency for Healthcare Research and Quality (AHRQ)	Nonemergent percutaneous coronary intervention versus optimal medical treatment for stable ischemic heart disease: a rapid response literature review
2023	Agency for Healthcare Research and Quality (AHRQ)	Measuring healthcare organization characteristics in cancer care delivery research
2023	Agency for Healthcare Research and Quality (AHRQ)	Management of postpartum hypertensive disorders of pregnancy
2023	Agency for Healthcare Research and Quality (AHRQ)	Living systematic review on cannabis and other plant-based treatments for chronic pain
2023	Agency for Healthcare Research and Quality (AHRQ)	Efficacy of dental services for reducing adverse events in those undergoing insertion of implantable cardiovascular devices
2023	Agency for Healthcare Research and Quality (AHRQ)	Efficacy of dental services for reducing adverse events in those receiving chemotherapy for cancer
2023	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Fenfluramine (Dravet syndrome, ≥ 2 years)]
2023	Austrian Institute for Health Technology Assessment (AIHTA)	Robot-assisted surgery in thoracic and visceral indications – Update 2023
2023	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Sutimlimab (cold agglutinin disease)]
2023	Health Information and Quality Authority (HIQA)	Expansion of the childhood immunisation schedule to include varicella (chickenpox) vaccination: health technology assessment
2023	Health Information and Quality Authority (HIQA)	Interventions to improve long COVID symptoms: a systematic review
2023	Health Information and Quality Authority (HIQA)	A slot-scanning, biplanar, digital X-ray imaging system for the evaluation and monitoring of orthopaedic conditions: evidence synthesis to support a generic justification decision
2023	Health Information and Quality Authority (HIQA)	Lutetium oxodotreotide for the treatment of metastatic or inoperable gastroenteropancreatic neuroendocrine tumours (GEP-NETs): evidence synthesis to support a generic justification decision
2023	Adelaide Health Technology Assessment (AHTA)	Review of different minimally invasive therapeutic approaches for the management of patients with benign prostatic hyperplasia
2023	Penn Medicine Center for Evidence-based Practice (CEP)	Nurse-driven protocols for antibiotic initiation in febrile neutropenia
2023	Austrian Institute for Health Technology Assessment (AIHTA)	Electrical auricular vagus nerve stimulation for pain
2023	Austrian Institute for Health Technology Assessment (AIHTA)	Bleomycin electrosclerotherapy for vascular anomalies
2023	Austrian Institute for Health Technology Assessment (AIHTA)	Transcranial magnetic resonance-guided high-intensity focused ultrasound treatment in patients with drug-resistant essential tremor
2023	Austrian Institute for Health Technology Assessment (AIHTA)	Percutaneous aspiration thrombectomy for pulmonary embolism
2023	Austrian Institute for Health Technology Assessment (AIHTA)	177Lu-PSMA radioligand therapy in patients with metastatic castration-resistant prostate cancer: Update 2023 - systematic review
2023	Austrian Institute for Health Technology Assessment (AIHTA)	Allogeneic mesenchymal stem cells for Crohn's disease-associated complex perianal fistulas. Update 2023
2023	Austrian Institute for Health Technology Assessment (AIHTA)	Percutaneous mitral valve repair with a clip device in patients with mitral regurgitation. Update 2023
2023	NIHR Health Services and Delivery Research programme	The effects of computerised decision support systems on nursing and allied health professional performance and patient outcomes: a systematic review and user contextualisation
2023	NIHR Health Services and Delivery Research programme	Youth violence intervention programme for vulnerable young people attending emergency departments in London: a rapid evaluation
2023	NIHR Health Services and Delivery Research programme	New and emerging technology for adult social care - the example of home sensors with artificial intelligence (AI) technology
2023	NIHR Health Services and Delivery Research programme	Early evaluation of the Children and Young People's Mental Health Trailblazer programme: a rapid mixed-methods study
2023	NIHR Health Services and Delivery Research programme	Towards achieving interorganisational collaboration between health-care providers: a realist evidence synthesis
2023	NIHR Health Services and Delivery Research programme	Thinking ahead about medical treatments in advanced illness: a qualitative study of barriers and enablers in end-of-life care planning with patients and families from ethnically diverse backgrounds
2023	NIHR Health Services and Delivery Research programme	A multimethod study of NHS 111 online
2023	NIHR Health Services and Delivery Research programme	Factors which facilitate or impede patient engagement with pulmonary and cardiac rehabilitation: a rapid evaluation mapping review
2023	NIHR Health Technology Assessment programme	Antibiotics for lower respiratory tract infection in children presenting in primary care: ARTIC-PC RCT
2023	NIHR Health Technology Assessment programme	Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies
2023	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Valoctocogene roxaparvovec (severe haemophilia A)]
2023	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Brexucabtagene Autoleucel (new therapeutic indication: relapsed or refractory B-cell precursor acute lymphoblastic leukaemia, 26 years of age and above)]
2023	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Asciminib (chronic myeloid leukaemia, Ph+, after ≥ 2 prior therapies)]
2023	Health Information and Quality Authority (HIQA)	Health technology assessment of domiciliary invasive ventilation for adults with spinal cord injuries
2023	Health Information and Quality Authority (HIQA)	International review of the epidemiology of long COVID
2023	Penn Medicine Center for Evidence-based Practice (CEP)	Urine pregnancy screening for patients with and without the capacity for pregnancy
2023	Austrian Institute for Health Technology Assessment (AIHTA)	Perinatal and infant mental health care in Austria. A mapping of existing prevention, screening and care structures, with a specific focus on Tyrol
2023	Penn Medicine Center for Evidence-based Practice (CEP)	Guidelines and clinical pathways for management of acute lower GI bleeding
2023	NIHR Health Technology Assessment programme	Clinical and cost effectiveness of endoscopic bipolar radiofrequency ablation for the treatment of malignant biliary obstruction: a systematic review
2023	Finnish Coordinating Center for Health Technology Assessment (FinCCHTA)	Thermidas thermal imaging system
2023	NIHR Health Technology Assessment programme	Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial
2023	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Trends in utilisation of ultrasound by older Australians (2010-2019)
2023	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	The clinical effectiveness of denosumab (Prolia) in patients with hormone-sensitive cancer receiving endocrine therapy, compared to bisphosphonates, selective estrogen receptor modulators (SERM), and placebo: a systematic review and network meta-analysis
2023	NIHR Health and Social Care Delivery Program	Mental health crisis care for children and young people aged 5 to 25 years: the CAMH-Crisis evidence synthesis
2023	Austrian Institute for Health Technology Assessment (AIHTA)	Oral and parenteral preexposure prophylaxis (PrEP) to prevent HIV in people at risk: a systematic review of clinical effectiveness and safety with assessment of organisational, economic, patient/social, ethical and legal elements
2023	Scottish Health Technologies Group (SHTG)	Orthotic bracing for the treatment of idiopathic scoliosis in children and young people (less than 18 years)
2023	Scottish Health Technologies Group (SHTG)	Store-and-forward teledermatology for triage of primary care referrals
2023	Scottish Health Technologies Group (SHTG)	Consideration of selective internal radiation therapies (SIRT) for treating primary hepatocellular carcinoma (liver cancer)
2023	Scottish Health Technologies Group (SHTG)	An assessment of the Feeling Good app